Dr Jihad Mustapha (Advanced Cardiac & Vascular Centers, Grand Rapids, US) discusses the SAVAL trial - Next steps in drug-eluting stents for BTK intervention.

Filmed by Radcliffe Vascular.

Questions:

1. Why was the SAVAL trial needed? (00:10)

2. What was the study design? (00:42)

3. What is novel about this particular stent? (01:24)

4. If this trial is positive, how might this trial change practice when it comes to CLI? (02:30)

5. Why do you think SAVAL will be successful when other CLI trials have failed? (03:25)

6. A recent meta-analysis has raised safety concerns in the use of paclitaxel coated devices in PAD. What is your take on this? (04:27)

Videographer: Tom Green

Educational lead: Liam O'Neill